Carvacrol alters soluble factors in HCT-116 and HT-29 cell lines

dc.authorid0000-0002-0675-1839
dc.contributor.authorPakdemirli, Ahu
dc.contributor.authorKaraca, Caner
dc.contributor.authorSever, Tolga
dc.contributor.authorDaskın, Ezgi
dc.contributor.authorLeblebici, Asım
dc.contributor.authorYiğitbaşı, Türkan
dc.contributor.authorBaşbınar, Yasemin
dc.date.accessioned2020-04-20T12:32:58Z
dc.date.available2020-04-20T12:32:58Z
dc.date.issued2020
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Temel Tıp Bilimleri Bölümü, Tıbbi Biyokimya Ana Bilim Dalı
dc.description.abstractBackground/aim: Natural products are popular insights for researchers to investigate promising anti-cancer agents since some of these substances have lesser adverse effects restricting the treatment than traditional chemotherapeutic agents. A well-known monoterpene Carvacrol, widely consumed in Mediterranean cuisine and lower risks of cancer, has efficient anticancer effects. However, the mechanism of action is yet to be discovered.Materials and methods: The investigation aims to illuminate a new perceptive in the role of this substance on colorectal cancer treatment, by the means of differences in a well-defined range of soluble factors. Carvacrol effect on both HT-29 and HCT-116 cell lines was evaluated on proliferation and the IC 50 values were calculated by the RTCA xCELLigence device. Then MAGPIX assay was performed to obtain the changes in soluble factors of the cell lines.Results: The Multiplexing assay suggests some of these factors were altered in favor of surviving and proliferation in aggressive cell line HCT-116 whereas they were altered against these characters in HT-29, were correlated with the increased IC50 concentration of HCT116 in carvacrol treatment.Conclusion: The current study indicates that differences in the levels of these soluble factors could modulate the anticancer effect related to carvacrol.
dc.identifier.citationPakdemirli, A., Karaca, C., Sever, T., Daskın, E., Leblebici, A., Yiğitbaşı, T. ... Başbınar, Y. (2020). Carvacrol alters soluble factors in HCT-116 and HT-29 cell lines. Turkish Journal of Medical Sciences, 50(1), 271-276. https://dx.doi.org/10.3906/sag-1907-173
dc.identifier.doi10.3906/sag-1907-173
dc.identifier.endpage276
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue1
dc.identifier.scopusqualityQ3
dc.identifier.startpage271
dc.identifier.urihttps://hdl.handle.net/20.500.12511/5180
dc.identifier.urihttps://dx.doi.org/10.3906/sag-1907-173
dc.identifier.volume50
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTUBITAK Scientific & Technical Research Council Turkey
dc.relation.ispartofTurkish Journal of Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/us/*
dc.subjectCarvacrol
dc.subjectPhytochemical
dc.subjectColon Cancer
dc.subjectSoluble Factors
dc.titleCarvacrol alters soluble factors in HCT-116 and HT-29 cell lines
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Yigitbasi, Türkan-2020.pdf
Boyut:
477.54 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: